Skip to main content

Cough-Cold and Flu

  • HDA recognizes pharmaceutical and consumer product manufacturers with DIANA honors

    COLORADO SPRINGS, Colo. — The newly rebranded Healthcare Distribution Alliance on Tuesday recognized outstanding pharmaceutical and consumer product manufacturers with the annual Distribution Management Awards for Notable Achievements in Healthcare (DIANA).
     

  • HDMA rebranded as Healthcare Distribution Alliance

  • CDC: Despite extra month of flu, this season still mild compared to past three

    ATLANTA - The Centers for Disease Control and Prevention on Friday noted that the 2015-2016 influenza season was lower in terms of influenza activity and peaked later as compared to the three previous seasons in the June 10 issue of the Morbidity and Mortality Weekly Report. 
     
    Activity remained low from October 2015 until late December 2015 and peaked in mid-March 2016. According to the report, only two other seasons have peaked in March in the past 18 influenza seasons - 2011–12 and 2005–06. 
     

  • CHPA testifies on impact FDA's proposed OTC Monograph User Fees may have on innovation

    WASHINGTON — Testifying before the Food and Drug Administration, the Consumer Healthcare Products Association on Friday expressed cautious optimism on the impact OTC Monograph User Fees may have on OTC innovation. 
     

  • Hand sanitizer shown to reduce health insurance claims by 24%

    AKRON, Ohio -- A new study reports that offices equipped with alcohol-based hand sanitizers had 24.3% fewer healthcare insurance claims for preventable illnesses – such as cold, flu and respiratory illnesses.

  • HRG to moderate front-end focused session at HDMA BLC

    WAUKESHA, Wis. – Hamacher Resource Group will serve as moderator of the session, “Ask the Distributors – How to Fuel the Front-end,” on June 13 at the Front-end Forum, part of the Healthcare Distribution Management Association Business and Leadership Conference at the Broadmoor Resort in Colorado Springs, Colo., the company announced Tuesday. 
     

  • Alaska becomes 11th state to restrict DXM sales to adults

    JUNEAU, Alaska - Alaska recently became the 11th state to help prevent the growing abuse threat posed by products containing dextromethorphan by restricting the sale of products containing DXM to Alaskans over the age of 18, or under 18 with a licensed practitioner’s prescription.
     

  • Perrigo announces FDA approval of store brand equivalent to Flonase

    DUBLIN -  The national brand equivalent of GlaxoSmithKline's Flonase will soon be shipping to store shelves with the announcement Monday that Perrigo and its partner West-Ward Pharmaceuticals on Tuesday gained approval from the U.S. Food and Drug Administration.

    "This product approval and launch demonstrates the power of Perrigo's OTC platform," stated John Hendrickson, Perrigo CEO. "Our team has made significant efforts to bring this important product to our customers and consumers in the U.S."

X
This ad will auto-close in 10 seconds